Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator.

Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator.
复制标题

血管紧张素转换酶 2 (ACE2):SARS-CoV-2 受体和 RAS 调节剂

DOI:
10.1016/j.apsb.2020.10.006
复制
发表时间:
2021-01
期刊:
Acta pharmaceutica Sinica. B
影响因子:
--
通讯作者:
Li Z
Li Z
中科院分区:
其他
文献类型:
--
作者:
Bian J;Li Z

文献摘要

参考文献

被引文献

相似文献

2019年冠状病毒病(COVID-19)爆发是由严重急性呼吸道综合征冠状病毒2(SARS-CoV-2)引起的。血管紧张素转换酶2(ACE 2)是SARS冠状病毒2型的重要功能受体。ACE 2是众所周知的肾素-血管紧张素系统(RAS)的反调节剂,并且在心血管系统中起关键作用。鉴于ACE 2同时作为SARS-CoV-2受体和RAS调节剂发挥作用,COVID-19的治疗面临着如何限制病毒进入但保护ACE 2生理功能的困境。因此,迫切需要对ACE 2的研究进展及其与病毒的关系进行深入总结,为解决这一难题提供可能。在这里,我们总结了冠状病毒,ACE 2和RAS(包括抗RAS药物)之间的复杂性和相互作用。我们提出了SARS-CoV-2感染功能受体的五种新的工作模式和ACE 2介导的病毒进入宿主细胞的途径及其调控机制。对于抗RAS药物应用的争议,我们也进行了理论分析和药物应用的讨论。这些将有助于更深入地了解病毒与ACE 2之间关系的复杂机制,并为病毒干预策略提供指导。本文综述了冠状病毒、ACE 2和RAS(包括抗RAS药物)之间的复杂性和相互作用。
The coronavirus disease 2019 (COVID-19) outbreak is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme 2 (ACE2) was rapidly identified as the critical functional receptor for SARS-CoV-2. ACE2 is well-known as a counter-regulator of the renin-angiotensin system (RAS) and plays a key role in the cardiovascular system. Given that ACE2 functions as both a SARS-CoV-2 receptor and a RAS modulator, the treatment for COVID-19 presents a dilemma of how to limit virus entry but protect ACE2 physiological functions. Thus, an in-depth summary of the recent progress of ACE2 research and its relationship to the virus is urgently needed to provide possible solution to the dilemma. Here, we summarize the complexity and interplay between the coronavirus, ACE2 and RAS (including anti-RAS drugs). We propose five novel working modes for functional receptor for SARS-CoV-2 infection and the routes of ACE2-mediated virus entering host cells, as well as its regulatory mechanism. For the controversy of anti-RAS drugs application, we also give theoretical analysis and discussed for drug application. These will contribute to a deeper understanding of the complex mechanisms of underlying the relationship between the virus and ACE2, and provide guidance for virus intervention strategies. This review summarizes the complexity and interplay between the coronavirus, ACE2 and RAS (including anti-RAS drugs).
DOI: 10.1186/1465-9921-6-8
发表时间: 2005-01-20
影响因子: 5.8
作者:
Groneberg DA;Hilgenfeld R;Zabel P
通讯作者: Zabel P
DOI: 10.1016/j.apsb.2020.04.007
发表时间: 2020-07-01
影响因子: 14.5
作者:
Cui, Cheng;Zhang, Miao;Liu, Dongyang
通讯作者: Liu, Dongyang
DOI: 10.1042/cs20120162
发表时间: 2012-12-01
期刊: CLINICAL SCIENCE
影响因子: 6
作者:
Burchill, Luke J.;Velkoska, Elena;Burrell, Louise M.
通讯作者: Burrell, Louise M.
DOI: 10.1136/thoraxjnl-2013-204403
发表时间: 2014-07-01
期刊: THORAX
影响因子: 10
作者:
Clark, Peter
通讯作者: Clark, Peter
DOI: 10.4238/2015.august.19.11
发表时间: 2015-01-01
影响因子: 0.4
作者:
Cervantes, M.;Arce, N.;Morales, A.
通讯作者: Morales, A.